Home › Categories › Corporate Reports› Immunovia Restructures

Immunovia Restructures.pdf

2184424.pdf

🔗 Source: mb.cision.com

📊 Size: 160 KB

👤 Author: Laura Chirica

⬇️ Downloads: 84

Summary

Immunovia will restructure to focus on its next-generation blood test for pancreatic cancer detection, ceasing commercialization of its IMMray PanCan-d test in the US. The new test is expected to provide accurate results across multiple patient risk groups and reduce reliance on CA19-9, with an anticipated launch date in 2024. This decision will result in significant layoffs and reduced operating expenses, extending the company's cash reserves into 2024.

Download File

Description

Immunovia will restructure to focus on its next-generation blood test for pancreatic cancer detection, ceasing commercialization of its IMMray PanCan-d test in...

Technical Information

File Format: PDF
File Size: 160 KB
Pages: 2
Language: EN
Author: Laura Chirica
Total Downloads: 84
Last Updated: 1 week ago

Document Overview

This PDF document about Immunovia Restructures provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Immunovia Restructures.